Invitrocue Competitors and Similar CompaniesClear all

Invitrocue's competitors and similar companies include Epsilogen and Artiva Biotherapeutics.

	Invitrocue Invitrocue is a life sciences company that specializes in developing 3D cell-based models derived from liver and tumour tissues.	Epsilogen Epsilogen (formerly IGEM Therapeutics) is an immuno-oncology company specializing in the development of IgE antibody drugs to fight cancer.	Artiva Biotherapeutics Artiva Biotherapeutics is a company that develops off-the-shelf cell therapies designed to treat hematologic malignancies or solid tumors.
Founding Date	Founding Date 2012	Founding Date 2017	Founding Date 2019
Type	Type Public	Type Private	Type Public
Tags	Tags Healthcare 3d modeling biotech life sciences oncology	Tags Healthcare biotech life sciences oncology	Tags Healthcare biotech drug development oncology therapy
Locations	Locations Singapore, SG HQ Sydney, AU Su Zhou Shi, CN München, DE Madrid, ES	Locations Reading, GB HQ London, GB	Locations San Diego, US HQ
Employees	Employees N/A	Employees 28	Employees 81
Financial
Net income	Net income ($6.7m) (FY, 2019)	Net income N/A	Net income ($83.9m) (FY, 2025)

For sources of this data, please see the company profile

Reading, GB

Employees

Epsilogen (formerly IGEM Therapeutics) is an immuno-oncology company specializing in the development of IgE antibody drugs to fight cancer.

San Diego, US

Employees

Artiva Biotherapeutics is a company that develops off-the-shelf cell therapies designed to treat hematologic malignancies or solid tumors.

Financial